Detalles de la búsqueda
1.
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
PLoS Med
; 17(10): e1003348, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125391
2.
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta.
Mult Scler Relat Disord
; 63: 103815, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508100
3.
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.
Neurology
; 91(24): e2265-e2275, 2018 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413632
4.
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
PLoS One
; 12(2): e0170395, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28170401
5.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
PLoS One
; 11(11): e0162752, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806057
Resultados
1 -
5
de 5
1
Próxima >
>>